Improves Insulin Sensitivity Diabetes occurs when the body doesnt produce enough insulin, or when it cant use the insulin it produces
The primary goal of this article is to emphasize the extensive benefits of using GLP-1RAs in treating a broad spectrum of diseases, such as obesity, cardiovascular diseases, non-alcoholic fatty liver disease (NAFLD), neurodegenerative diseases, musculoskeletal inflammation, and various forms of cancer
Methods: Seventy-nine healthy study participants of both sexes, who were diagnosed with AGA were divided into 4 study groups
Examples include humanized monoclonal antibodies (antibodies manufactured in the laboratory from identical immune cells), which target specific antibodies or cytokines
The drug was used in a double-blind, randomised, placebo-controlled trial including 526 adult participants with type 2 diabetes across China, India, Japan, Mexico, and the United States